Novozymes CFO: Powerful momentum in bioenergy division

Comprehensively, we are seeing a powerful momentum in the division, says the company's chief financial officer.

Bioenergy sales, which for Novozymes consists of enzyme sales for bioethanol production, showed an organic growth rate of 5 percent in the fourth quarter of 2018.

This is not quite as high as sales from the same quarter in 2017, which was booked at 14 percent. Novozymes is, however, impacted by large bioethanol inventories accumulated in the US.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Further reading

Related articles

Latest News

See all jobs